Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma
2017 ◽
Vol 110
(3)
◽
pp. 290-303
◽
2020 ◽
Vol 98
◽
pp. 192-201
◽
Keyword(s):
2006 ◽
Vol 2006
◽
pp. 353-354
2006 ◽
Vol 2006
◽
pp. 352-353
1996 ◽
Vol 132
(7)
◽
pp. 833-834
◽
1996 ◽
Vol 132
(11)
◽
pp. 1353-1357
◽
Keyword(s):